ArticleCerebellum (London, England)2026
Remote Online-Based Application of the Cerebellar Cognitive Affective Syndrome Scale.
Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The Cerebellar Cognitive Affective Syndrome Scale (CCAS-S) is increasingly used in clinical trials to assess non-motor function in cerebellar disorders, yet its suitability for remote administration has not been evaluated. Using a matched-pairs design, we compared remote, video-based administration of the German CCAS-S (version A) in 22 patients with cerebellar disease and 22 matched controls with at site -testing from a larger, previously tested cohort. Group matching included age, level of education, sex, occupational experience, and ataxia severity. Uncorrected as well as age, education and sex corrected CCAS-S scores were analysed. Test-retest and interrater reliability were assessed in subsets of the remote cohort. Remotely tested patients did not perform worse than at site tested patients regarding the number of failed test items or the total sum raw score. Instead, fewer significant group differences on single test items emerged in the remote cohort between patients and controls compared to the at site tested cohort. Test-retest reliability of remote CCAS-S administration was good in patients and in controls, and interrater reliability was good to excellent. The coefficients were of a similar magnitude as the published values for at site administration, but were not compared statistically because of differences in study design and small subgroup sizes. Remote administration of the CCAS-S is feasible and shows good test-retest and interrater reliability. However, the present cohort-comparison design does not permit conclusions regarding measurement equivalence between remote and at site administration. Until equivalence has been established in a within-subject crossover design, remote and at site CCAS-S data should not be pooled, and remotely assessed patients should be compared against remotely assessed controls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.